newsfilter
← Latest News
Business Wire·

Humanigen to Present at BIO CEO & Investor Conference

Humanigen, Inc. (NASDAQ:HGEN), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm,' announced today that Timothy E. Morris, COO/CFO, will be presenting at the upcoming 2022 BIO